Opendata, web and dolomites


Revealing the ubiquitin and ubiquitin-like modification landscape in health and disease

Total Cost €


EC-Contrib. €






 Ubl-Code project word cloud

Explore the words cloud of the Ubl-Code project. It provides you a very rough idea of what is the project "Ubl-Code" about.

determined    biological    vitro    decipher    ptms    understand    enzymatic    analyze    modifications    ms    fundamental    broadened    regulatory    regulate    code    modified    broadly    underlying    paradigm    backbone    network    translational    edge    specificity    landscape    downstream    sequence    tool    ubl    relatively    decade    machinery    monitor    unexplored    imaging    molecular    remained    stability    appropriate    variety    recognition    dynamic    deciphering    enzymes    events    revealing    signalling    proteomic    progression    form    regulation    amino    principles    technologies    modifying    acid    substrate    specify    operate    profiling    questions    vivo    transcriptional    post    reveal    ample    differentiation    pathogenesis    characterization    substrates    profoundly    mechanisms    rely    localization    cellular    therapeutics    function    subsequent    basis    implicated    throughput    shown    initiate    diseases    cell    proteins    uses    cancer    genomic    ubiquitin    cutting    ptm    protein    conjugation    opportunity    aberrations    dynamics    elucidate    utilize    division   

Project "Ubl-Code" data sheet

The following table provides information about the project.


Organization address
address: HERZL STREET 234
postcode: 7610001

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 1˙500˙000 €
 EC max contribution 1˙500˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2015-STG
 Funding Scheme ERC-STG
 Starting year 2016
 Duration (year-month-day) from 2016-05-01   to  2021-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) coordinator 1˙500˙000.00


 Project objective

Post-translational modifications (PTMs) of proteins are a major tool that the cell uses to monitor events and initiate appropriate responses. While a protein is defined by its backbone of amino acid sequence, its function is often determined by PTMs, which specify stability, activity, or cellular localization. Among PTMs, ubiquitin and ubiquitin-like (Ubl) modifications were shown to regulate a variety of fundamental cellular processes such as cell division and differentiation. Aberrations in these pathways have been implicated in the pathogenesis of cancer. Over the past decade high-throughput genomic and transcriptional analyses have profoundly broadened our understanding of the processes underlying cancer development and progression. Yet, proteomic analyses and the PTM landscape in cancer, remained relatively unexplored. Our goal is to decipher molecular mechanisms of Ubl regulation in cancer. We will utilize the PTM profiling technology that I developed and further develop it to allow for subsequent MS analysis. Together with cutting-edge genomic, imaging and proteomic technologies, we will analyze novel aspects of PTM regulation at the level of the enzymatic machinery, the substrates and the downstream cellular network. We will rely on ample in-vitro and in-vivo characterization of Ubl conjugation to:a. Elucidate the regulatory principles of substrate specificity and recognition. b. Understand signalling dynamics in the ubiquitin system. c. Reveal how aberrations in these pathways may lead to diseases such as cancer. Identifying both the Ubl modifying enzymes and the modified substrates will form the basis for deciphering the molecular pathways in which they operate in the cell and the principles of their dynamic regulation. Revealing the PTM regulatory code presents a unique opportunity for the development of novel therapeutics. More broadly, our approaches may provide a new paradigm for addressing other complex biological questions involving PTM regulation.


year authors and title journal last update
List of publications.
2018 Hila Wolf-Levy, Aaron Javitt, Avital Eisenberg-Lerner, Assaf Kacen, Adi Ulman, Daoud Sheban, Bareket Dassa, Vered Fishbain-Yoskovitz, Carmelo Carmona-Rivera, Matthias P Kramer, Neta Nudel, Ifat Regev, Liron Zahavi, Dalia Elinger, Mariana J Kaplan, David Morgenstern, Yishai Levin, Yifat Merbl
Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides
published pages: 1110-1116, ISSN: 1087-0156, DOI: 10.1038/nbt.4279
Nature Biotechnology 36/11 2019-06-05
2017 Avital Eisenberg-Lerner, Ifat Regev, Yifat Merbl
Post-Translational Modification Profiling-Functional Proteomics for the Analysis of Immune Regulation
published pages: 139-152, ISSN: , DOI: 10.1007/978-1-4939-7201-2_9
Methods in Molecular Biology 2019-06-19
2016 Avital Eisenberg-Lerner, Aaron Ciechanover, Yifat Merbl
Post-translational modification profiling – A novel tool for mapping the protein modification landscape in cancer
published pages: 1475-1482, ISSN: 1535-3702, DOI: 10.1177/1535370216651732
Experimental Biology and Medicine 241/14 2019-06-19

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UBL-CODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UBL-CODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

TroyCAN (2020)

Redefining the esophageal stem cell niche – towards targeting of squamous cell carcinoma

Read More  

InsideChromatin (2019)

Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin Domains

Read More  


3D printed micro- and nano-optics for future integrated vision and endoscopy systems

Read More